| 19.65 0.64 (3.37%) | 04-16 16:00 | |||||||||||||
|
|
| Short term |  |
|||
| Mid term | |
|||
| Targets | 6-month : | 23.31  |
1-year : | 27.22 |
| Resists | First : | 19.95 |
Second : | 23.31 |
| Pivot price | 17.17 |
|||
| Supports | First : | 16.75 |
Second : | 14.77 |
| MAs | MA(5) : | 18.08 |
MA(20) : | 16.7 |
| MA(100) : | 27.38  |
MA(250) : | 39.56 |
|
| MACD | MACD : | 0 |
Signal : | -0.5 |
| %K %D | K(14,3) : | 90.4 |
D(3) : | 80.5 |
| RSI | RSI(14): 60.5 |
|||
| 52-week | High : | 74.06 | Low : | 12.03 |
Price has closed above its short-term moving average. Short-term moving average is currently above mid-term; and below long-term moving average. From the relationship between price and moving averages: This stock is BULLISH in short-term; and NEUTRAL in mid-long term.[ CTEV ] has closed above the upper band by 5.1%. If price is in a uptrend band; this upward trend in price might continue. However a short term pullback inside the band is likely.Bollinger Bands are 67.7% narrower than normal. The narrow width of the bands suggests low volatility as compared to its normal range. The bands have been in this narrow range for 23 bars. This is a sign that the market may be about to initiate a new trend.
| If tomorrow: | Open lower | Open higher |
| High: | 19.96 - 20.03 | 20.03 - 20.1 |
| Low: | 17.64 - 17.72 | 17.72 - 17.8 |
| Close: | 19.51 - 19.63 | 19.63 - 19.75 |
Claritev Corporation, together with its subsidiaries, provides data analytics and technology-enabled cost management, payment, and revenue integrity solutions to the healthcare industry in the United States. The company offers analytics-based services that reduce medical costs, through data-driven algorithms and insights that detect claims over-charges and negotiate or recommend reimbursement; and network-based services that provide contracted discounts with healthcare providers, as well as outsourced network development and management services. It provides payment and revenue integrity services, such as identifying and removing improper and unnecessary charges paid during the claim, as well as services to identify and help restore and preserve underpaid premium dollars. In addition, the company offers data and decision science services including a suite of solutions that apply modern methods of data science to produce descriptive, predictive, and prescriptive analytics that drive optimized benefit plan design, support decision-making, improve clinical outcomes, and reduce the total cost of care; and business-to-business healthcare payments and other services. It serves national and regional insurance companies, Blue Cross and Blue Shield plans, provider-sponsored and independent health plans, TPAs, self-insured health plans, property and casualty insurers, bill review companies, and other companies involved in the claim adjudication process. The company was formerly known as MultiPlan Corporation and changed its name to Claritev Corporation in February 2025. Claritev Corporation was founded in 1980 and is headquartered in New York, New York.
Wed, 15 Apr 2026
Claritev (CTEV) price target decreased by 26.64% to 66.10 - MSN
Fri, 10 Apr 2026
Is Claritev Corp (CTEV) a Bargain After 9.2% Drop? GF Value Says Undervalued - GuruFocus
Wed, 08 Apr 2026
CTEV SEC Filings - Claritev Corp 10-K, 10-Q, 8-K Forms - Stock Titan
Thu, 02 Apr 2026
Claritev (CTEV) SVP receives 2,956 RSUs vesting from 2027 to 2030 - Stock Titan
Wed, 18 Mar 2026
Claritev Corporation (CTEV) Analyst/Investor Day - Slideshow (NYSE:CTEV) 2026-03-18 - Seeking Alpha
Tue, 24 Feb 2026
Claritev Corp (NYSE:CTEV) Posts Mixed Q4 Results with Wider Loss, Steady Revenue - ChartMill
| Price to Book Value: P/BV, a ratio used to compare book value to its current market price, to gauge whether a stock is valued properly. |
Underperform |
| Price to Earnings: PE, the ratio for valuing a company that measures its current share price relative to its earnings per share (EPS). |
Underperform |
| Discounted cash flow: DCF, a valuation method used to estimate the value of an investment based on its expected future cash flows. |
Neutral |
| Return on Assets: ROA, indicates how profitable a company is in relation to its total assets, how efficiently uses assets to generate a profit. |
Underperform |
| Return on Equity: ROE, a measure of financial performance calculated by dividing net income by equity. a gauge of profitability and efficiency. |
Outperform |
| Debt to Equity: evaluate financial leverage, reflects the ability of equity to cover outstanding debts in the event of a business downturn. |
Underperform |
|
Exchange:
NYSE
|
|
|
Sector:
Healthcare
|
|
|
Industry:
Medical - Healthcare Information Services
|
|
| Shares Out | 17 (M) |
| Shares Float | 5 (M) |
| Held by Insiders | 7 (%) |
| Held by Institutions | 91.6 (%) |
| Shares Short | 1,210 (K) |
| Shares Short P.Month | 966 (K) |
| EPS | -17.3 |
| EPS Est Next Qtrly | 0 |
| EPS Est This Year | 0 |
| EPS Est Next Year | 0 |
| Book Value (p.s.) | -10.52 |
| Profit Margin | -29.5 % |
| Operating Margin | 9.7 % |
| Return on Assets (ttm) | 1.1 % |
| Return on Equity (ttm) | 0 % |
| Qtrly Rev. Growth | 6.1 % |
| Gross Profit (p.s.) | 41.95 |
| Sales Per Share | 56.88 |
| EBITDA (p.s.) | 31.55 |
| Qtrly Earnings Growth | 0 % |
| Operating Cash Flow | 117 (M) |
| Levered Free Cash Flow | 166 (M) |
| PE Ratio | -1.14 |
| PEG Ratio | 0 |
| Price to Book value | -1.87 |
| Price to Sales | 0.34 |
| Price to Cash Flow | 2.84 |
| Dividend | 0 |
| Forward Dividend | 0 |
| Dividend Yield | 0% |
| Dividend Pay Date | Invalid DateTime. |
| Ex-Dividend Date | Invalid DateTime. |
|
|
|
|
|
|
|
|
|